Roche's flu med Xofluza drives drug resistance and may be a bad choice for kids, study says

A few days after an 11-year-old boy in Japan was diagnosed with the H3N2 strain of the flu and prescribed Xofluza from Roches Genentech, he stopped responding to the drug. Then his sister came down with the virus. Genetic testing showed she had a mutated form…
Read More